Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (191-200 of 740) with videos related to

Pageof 74
Sort By:
Emerging Infectious Diseases|June 23, 2004
Reference group choice and antibiotic resistance outcomesKeith S Kaye, John J Engemann, Essy Mozaffari, et al.
Lancet (London, England)|August 2, 1997
Good manners for the pharmaceutical industryH Calvert, S Kaye, R Osborne, et al.
Journal of Virological Methods|December 22, 1999
A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cellsJ M Bennett, S Kaye, N Berry, et al.
Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II studies of mitozolomide in melanoma, lung and ovarian cancerM Harding, V Docherty, R Mackie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve MonitoringJack Chang, Jiajun Liu, Keith S Kaye, et al.
Cancer|July 15, 1995
Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studiesS Monfardini, R Sorio, G H Boes, et al.
Annals of the Rheumatic Diseases|May 18, 2005
Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristicsA R Clewes, J K Dawson, S Kaye, et al.
Journal of Medical Virology|February 1, 1991
Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS diseaseK K Goswami, S Kaye, R Miller, et al.
The Lancet. Infectious Diseases|July 13, 2023
Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' replyKeith S Kaye, Sarah M McLeod, John P O'Donnell, et al.
Pageof 74

Showing results (191-200 of 740) with videos related to

Sort By:
Pageof 74
Emerging Infectious Diseases|June 23, 2004
Reference group choice and antibiotic resistance outcomesKeith S Kaye, John J Engemann, Essy Mozaffari, et al.
Lancet (London, England)|August 2, 1997
Good manners for the pharmaceutical industryH Calvert, S Kaye, R Osborne, et al.
Journal of Virological Methods|December 22, 1999
A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cellsJ M Bennett, S Kaye, N Berry, et al.
Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II studies of mitozolomide in melanoma, lung and ovarian cancerM Harding, V Docherty, R Mackie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve MonitoringJack Chang, Jiajun Liu, Keith S Kaye, et al.
Cancer|July 15, 1995
Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studiesS Monfardini, R Sorio, G H Boes, et al.
Annals of the Rheumatic Diseases|May 18, 2005
Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristicsA R Clewes, J K Dawson, S Kaye, et al.
Journal of Medical Virology|February 1, 1991
Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS diseaseK K Goswami, S Kaye, R Miller, et al.
The Lancet. Infectious Diseases|July 13, 2023
Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' replyKeith S Kaye, Sarah M McLeod, John P O'Donnell, et al.
Pageof 74